Tag Archives: We can stop COVID-19: Moderna vaccine success gives world more hope

Moderna’s experimental vaccine was 94.5% effective in preventing COVID-19 based on interim data from a late-stage trial, the company said on Monday, becoming the second U.S. drugmaker to report results that far exceed expectations. Together with Pfizer’s vaccine, which is also more than 90% effective, and pending more safety data and regulatory review, the United States could have two vaccines …

Read More »